These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24827996)

  • 1. Cytological nuclear atypia classification can predict prognosis in patients with endometrial cancer.
    Yamaguchi T; Kawahara A; Hattori S; Taira T; Abe H; Sanada S; Akiba J; Nishio S; Ushijima K; Kamura T; Kage M
    Cytopathology; 2015 Jun; 26(3):157-66. PubMed ID: 24827996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.
    Voss MA; Ganesan R; Ludeman L; McCarthy K; Gornall R; Schaller G; Wei W; Sundar S
    Gynecol Oncol; 2012 Jan; 124(1):15-20. PubMed ID: 21864888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-cytological study of uterine papillary serous carcinoma.
    Hagiwara T; Kaku T; Kobayashi H; Hirakawa T; Nakano H
    Cytopathology; 2005 Jun; 16(3):125-31. PubMed ID: 15924607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear morphometry as an adjunct to cytopathologic examination of endometrial brushings on LBC samples: A prospective approach to combined evaluation in endometrial neoplasms and look alikes.
    Norimatsu Y; Irino S; Maeda Y; Yanoh K; Kurokawa T; Hirai Y; Kobayashi TK; Fulciniti F
    Cytopathology; 2021 Jan; 32(1):65-74. PubMed ID: 32794283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of squamous cell change associated with endometrial carcinoma: A cytopathologic approach.
    Toomine Y; Watanabe S; Sugishima S; Ohishi Y; Tamiya S; Kobayashi H; Sonoda K; Oda Y; Kato K; Kaku T
    Diagn Cytopathol; 2016 Mar; 44(3):187-94. PubMed ID: 26715072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cytology in serous and endometrioid endometrial cancer.
    Roelofsen T; Geels YP; Pijnenborg JM; van Ham MA; Zomer SF; van Tilburg JM; Snijders MP; Siebers AG; Bulten J; Massuger LF
    Int J Gynecol Pathol; 2013 Jul; 32(4):390-8. PubMed ID: 23722512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial metaplasia: correlation of histological and cytological specimens obtained from 103 cases undergoing hysterectomy for endometrial carcinoma.
    Toomine Y; Watanabe S; Ohishi Y; Tamiya S; Sugishima S; Kobayashi H; Oda Y; Kaku T
    Cytopathology; 2014 Apr; 25(2):78-85. PubMed ID: 23517058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Architectural versus nuclear atypia-defined FIGO grade 2 endometrial endometrioid adenocarcinoma (EEC): a clinicopathologic comparison of 154 cases with clinical follow-up.
    Winham WM; Lin D; Stone PJ; Nucci MR; Quick CM
    Int J Gynecol Pathol; 2014 Mar; 33(2):120-6. PubMed ID: 24487465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological Study of Grade 3 Endometrioid Adenocarcinoma of Endometrial Origin: Cytoarchitecture and Features of Cell Clusters Assessed With Endometrial Brushing Cytology--Focusing on a comparison with endometrioid adenocarcinoma Grade 1, 2.
    Matsui N; Kajiwara H; Morishita A; Tsukada H; Nakazawa K; Miyazawa M; Mikami M; Nakamura N; Sato S
    Tokai J Exp Clin Med; 2015 Jun; 40(2):29-35. PubMed ID: 26150180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems.
    Alkushi A; Abdul-Rahman ZH; Lim P; Schulzer M; Coldman A; Kalloger SE; Miller D; Gilks CB
    Am J Surg Pathol; 2005 Mar; 29(3):295-304. PubMed ID: 15725797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation profiles of endometrioid and serous endometrial cancers.
    Seeber LM; Zweemer RP; Marchionni L; Massuger LF; Smit VT; van Baal WM; Verheijen RH; van Diest PJ
    Endocr Relat Cancer; 2010 Sep; 17(3):663-73. PubMed ID: 20488783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
    Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
    Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
    Feng W; Malpica A; Robboy SJ; Gudlaugsson E; Hua K; Zhou X; Baak JP
    Int J Gynecol Pathol; 2013 May; 32(3):299-306. PubMed ID: 23545579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic validity of neoplastic cells with notable nuclear atypia in endometrial cancer.
    Takeshima N; Hirai Y; Hasumi K
    Obstet Gynecol; 1998 Jul; 92(1):119-23. PubMed ID: 9649106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype?
    Skaznik-Wikiel ME; Ueda SM; Frasure HE; Rose PG; Fleury A; Grumbine FC; Fader AN
    Acta Cytol; 2011; 55(3):255-60. PubMed ID: 21525737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.
    Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC
    Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using classification and regression trees, liquid-based cytology and nuclear morphometry for the discrimination of endometrial lesions.
    Pouliakis A; Margari C; Margari N; Chrelias C; Zygouris D; Meristoudis C; Panayiotides I; Karakitsos P
    Diagn Cytopathol; 2014 Jul; 42(7):582-91. PubMed ID: 24273089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometrical Differences among Endometrial Endometrioid Carcinoma Grade 1, Grade 3, and Serous Carcinoma in Endometrial Liquid-Based Cytology Preparations.
    Odashima H; Yoshioka H; Minami K; Miyakawa K; Horie K; Norimatsu Y; Yanoh K; Watanabe J
    Acta Cytol; 2022; 66(6):524-531. PubMed ID: 36096095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.